Atlas Trials

CTx-1301 Comparative Bioavailability Study

Clinical trial NCT04138498 · COMPLETED

Trial details

NCT number
NCT04138498
Sponsor
Cingulate Therapeutics
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
ADHD
Start date
2019-12-06
Primary completion
2020-03-06
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.